Which company will be a major AI diagnostic tool provider by end of 2025?
Google Health • 25%
IBM Watson Health • 25%
Microsoft Healthcare • 25%
Other • 25%
Industry analysis reports
AI Outperforms Doctors in Ovarian Cancer Detection, Achieving 90% Accuracy Without Interference; 76% Accuracy with AI
Jan 8, 2025, 05:26 AM
A recent study from Karolinska Institutet in Sweden has demonstrated that artificial intelligence (AI) models can outperform human doctors in the detection of ovarian cancer. This finding highlights the potential of AI technology in enhancing diagnostic accuracy in oncology. In a separate study published in JAMA, researchers found that physicians using AI achieved a diagnostic accuracy of 76%, comparable to the 74% accuracy of those not using AI. Notably, when AI was utilized without any doctor intervention, the accuracy surged to 90%. Furthermore, a dataset involving 3,652 patients across 20 centers in eight countries indicated that an ultrasound-based AI model significantly reduced referrals to experts by 63% during a triage simulation, showcasing the robustness of AI across various systems and patient demographics. These studies collectively underscore the growing role of AI in medical diagnostics and its implications for patient care.
View original story
Philips Healthcare • 25%
IBM Watson Health • 25%
Google Health • 25%
GE Healthcare • 25%
Anthropic • 25%
OpenAI • 25%
Neither • 25%
Both • 25%
Microsoft • 25%
Google • 25%
Amazon • 25%
Other • 25%
Google DeepMind • 25%
IBM • 25%
Other • 25%
Microsoft • 25%
Google • 25%
Meta • 25%
Other • 25%
World Labs • 25%
Illumina • 25%
NVIDIA • 25%
IQVIA • 25%
Mayo Clinic • 25%
Microsoft acquires OpenAI • 25%
None of these acquisitions occur • 25%
Google acquires Anthropic • 25%
Amazon acquires Anthropic • 25%
Google • 25%
Other • 25%
Microsoft • 25%
OpenAI • 25%
Aiuni AI • 25%
The World Labs • 25%
Meshy AI • 25%
Meta 3D AI • 25%
Nvidia • 25%
Google • 25%
Other • 25%
Intel • 25%
Other • 25%
Oracle • 25%
Pfizer • 25%
Moderna • 25%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
Time Saving • 25%
Patient Demand • 25%
Cost Efficiency • 25%
Accuracy Improvement • 25%